Shareholders unfortunately will need to focus on the low hanging fruit deals (Wyon etc) and leave the big ones as a massive bonus.
Life science looks like it will get over the line before batteries.
It will be interesting to see how big Vidcare will actually be - The ongoing testing of AnteoBind NXT by Vidcare Innovations (Vidcare) is yielding promising results as we work to evaluate and optimize it for a specific project-
"Given these encouraging results and the progress toward completing the evaluation, AnteoTech anticipates finalising the program results and, contingent upon their continued success, entering into a commercial supply agreement. Further to this, Vidcare has expressed an interest in utilising the AnteoBind™ technology in other products and making AnteoBind NXT a critical component of their growing product pipeline."
The only problem I see I notice timeline now seem to be lass than forthcoming from the company.
Cheers
M.oz
ADO Price at posting:
1.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)